Fluorescent needle test for breast duct micro-lesions
Part of Cancer, Skin, Women’s health & pregnancy clinical trials.
This trial tests a new glowing needle that helps doctors find and sample tiny abnormal areas in breast ducts during surgery. It aims to make the procedure more precise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 75 years old.
- You are already scheduled to have breast duct removal surgery.
- You are able to understand and agree to the study plan.
- You are not pregnant or breastfeeding.
- You do not have a known allergy to quantum-dot materials or parts of the needle.
- You do not have active hepatitis B or C with a detectable virus level, unstable heart disease, or certain neurological or psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special needle that glows to help surgeons find and remove high-risk breast lesions. If you've already had a breast lesion found by ductoscopy and a duct excision, you might be able to join.
This study uses a blood test and a sample of nipple discharge to see if it can help doctors tell the difference between non-cancerous and cancerous conditions in the breast ducts. It aims to find a better way to diagnose intraductal disease without needing surgery right away.
This trial tests a new imaging system that helps surgeons see if cancer cells remain after breast-conserving surgery. It may reduce the need for a second surgery by giving real-time feedback on the removed tissue.
This trial tests a special dye technique used during breast cancer surgery. The dye helps doctors see if all cancer cells have been removed, which may lower the chance of needing a second surgery.
This study tests a special dye that helps surgeons see breast cancer tissue and nearby lymph nodes more clearly during surgery. The goal is to make sure all cancer is removed while sparing healthy tissue.
This study tests a special “marker” technique to help surgeons find affected lymph nodes in the armpit after chemotherapy. It may support more targeted surgery and help avoid unnecessary removal of healthy lymph nodes.
Hear when a new Nipple Discharge trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.